Artiva Biotherapeutics, Inc. ARTV Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeNet.
The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artiva Biotherapeutics, Inc.'s interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Artiva Biotherapeutics, Inc.'s interest income?
- Artiva Biotherapeutics, Inc. (ARTV) reported interest income of $912K in Q1 2026.
- How has Artiva Biotherapeutics, Inc.'s interest income changed year-over-year?
- Artiva Biotherapeutics, Inc.'s interest income decreased by 51.1% year-over-year, from $1.86M to $912K.
- What is the long-term trend for Artiva Biotherapeutics, Inc.'s interest income?
- Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s interest income has grown at a 53.3% compound annual growth rate (CAGR), from $2.54M to $5.96M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.